End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12,579 ARS | +2.26% | -0.39% | +24.12% |
04:54pm | J&J: launches open, secure digital ecosystem | CF |
03:46pm | J&J: promising results in Crohn's disease | CF |
Sales 2024 * | 88.79B 80,416B | Sales 2025 * | 92.1B 83,423B | Capitalization | 351B 317,492B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 3.95 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.81 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 131,900 |
Yield 2024 * |
3.31% | Yield 2025 * |
3.46% | Free-Float | 77.08% |
Latest transcript on Johnson & Johnson
1 day | +2.26% | ||
1 week | -0.39% | ||
Current month | +3.04% | ||
1 month | +10.48% | ||
3 months | +11.64% | ||
6 months | +27.29% | ||
Current year | +24.12% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 88-12-31 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 97-12-31 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 19-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 19-04-24 |
D. Davis
BRD | Director/Board Member | 72 | 14-06-18 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 09-10-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-19 | 12,579 | +2.26% | 2,038 |
24-06-18 | 12,300 | -0.13% | 4,560 |
24-06-14 | 12,317 | -0.17% | 4,871 |
24-06-13 | 12,338 | -2.30% | 13,713 |
24-06-12 | 12,628 | -1.38% | 22,138 |
End-of-day quote Buenos Aires S.E., June 18, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+53.96% | 803B | |
+18.35% | 324B | |
+11.13% | 303B | |
+16.96% | 243B | |
+2.25% | 228B | |
+11.15% | 217B | |
+6.64% | 164B | |
-3.44% | 155B | |
-1.84% | 117B |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock